Clinical Trial Update: Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Botensilimab and Balstilimab with or without Regorafenib for microsatellite-stable advanced or metastatic colorectal cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)
• Stivarga (regorafenib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma | Phase 2 | Status: WITHDRAWN